Medical articles today

/* 728x15, */

Judy Riffle Elected International Fellow

Judy S. Riffle, professor of chemistry and director of Virginia Tech's Macromolecular Science and Engineering program, has been elected a Fellow in the Polymeric Materials Science and Engineering (PMSE) division of the American Chemical Society (ACS). Riffle was one of only three chemists worldwide to be named a PSME Fellow for 2010. She was recognized for her significant contributions to the science and engineering of polymeric materials. Riffle joined the chemistry department in the College of Science as an assistant professor in 1988. One of her many achievements has been the initiation and growth of interdepartmental graduate programs in macromolecular science and engineering.

Eribis Pharmaceuticals Receives Investment For Clinical Development Of Novel Cardiovascular Therapy

Eribis Pharmaceuticals AB part of the Karolinska Development portfolio announced that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material. In studies to date, Eribis' novel peptide therapy has shown excellent Cardio-protective effects in conditions of ACS and reperfusion.

/* 468x60, */

New Software Provides 3-D Views Of Arteries In Catheterization Lab

New technology that allows doctors to see three-dimensional images of heart arteries in the catheterization lab passed its first major testing hurdle - moving doctors closer to understanding its impact on clinical practice, researchers report in Circulation: Cardiovascular Interventions, an American Heart Association journal. Still in the early stages of testing, the 3-D images may allow cardiologists to more accurately and quickly assess the length, branching pattern, and angles of heart arteries and any blockages. "Coronary interventions may be improved by having a realistic, 3-D image of the coronary artery tree, " said John. D. Carroll, M.

Calls For Europe-Wide Salt Legislation Prompted By Study

"This study provides excellent ammunition both to convince patients about the benefits of reducing their individual salt intakes and also to persuade the EU of the urgent need to introduce legislation to restrict the salt content of processed foods, " said ESC spokesman Professor Frank Ruschitzka, a cardiologist and hypertension specialist from the University of Zurich, Switzerland. "This study represents the evidence that a reduction of salt intake not only lowers blood pressure but also prevents cardiovascular events. The case for population-wide salt reduction is now compelling, " he added. In the paper, Kirsten Bibbins-Domingo and colleagues, from the University of California, San Francisco, USA, undertook a computer simulation showing the effects of population wide reductions of dietary salt intakes in all adults aged 35 to 85 years in the USA.

Study Finds Common Heart Medications May Also Protect Against Parkinson's Disease

UCLA researchers have discovered that a specific type of medication used to treat cardiovascular conditions such as hypertension, angina and abnormal heart rhythms may also decrease the risk of developing Parkinson's disease. In the first large-scale population-based study of its kind, Dr. Beate Ritz, professor of epidemiology at the UCLA School of Public Health, in collaboration with researchers from the Danish Cancer Society, found that a specific sub-class of dihydropyridine cardiovascular medications was associated with a 26 to 30 percent decrease in the risk of Parkinson's. The findings appear in an upcoming print edition of the journal Annals of Neurology and are currently available online.

/* 468x60, */

Listen To Your Heart When It Comes To Substance Abuse And Mental Health

The Substance Abuse and Mental Health Services Administration (SAMHSA) would like to remind Americans that substance abuse and mental health problems affect those with heart disease. In fact, nearly a million Americans experiencing a serious psychological disorder in the past year also suffered from heart disease. Similarly more than a quarter of a million Americans who had a substance abuse disorder in the past year also experienced heart disease. So it's important for the health of your heart as well as your overall wellbeing that you seek help for any substance abuse or mental health problems you may be facing. By getting treatment you can lead a longer and happier life.

Rocket: [100]
/* 160x600, */
Medical articles today © Padayatra Dmitriy
Designer Dimitrov Dmytriy